27 Dec 2021 Bionest Addressing Gene Therapy Uncertainties Are we close to more streamlined and standardized approaches to gene therapy testing and regulations?
13 Dec 2021 Bionest UK Policy Changes Allow Earlier Access to Innovative Medicines for Rare Diseases Access to new treatments for rare diseases in the UK has often been a challenge. Will a new decision-making framework & funding improve the situation?